White blood cell count is associated with plasma total homocysteine in Japanese men

References

• Friedman G. D., Klatsky A. L., Siegelaub A. B. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974; 290: 1275–8
   PubMed Web of Science ®Google Scholar
• Grimm R. H., Jr, Neaton J. D., Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all‐cause mortality. J Am Med Assoc 1985; 254: 1932–7
   PubMed Web of Science ®Google Scholar
• de Labry L. O., Campion E. W., Glynn R. J., Vokonas P. S. White blood cell count as a predictor of mortality: results over 18 years from the Normative Aging Study. J Clin Epidemiol 1990; 43: 153–7
   PubMedGoogle Scholar
• Sweetnam P. M., Thomas H. F., Yarnell J. W., Baker I. A., Elwood P. C. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol 1997; 145: 416–21
   PubMed Web of Science ®Google Scholar
• Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C‐reactive protein, albumin, or leukocyte count with coronary heart disease. J Am Med Assoc 1998; 279: 1477–82
   PubMed Web of Science ®Google Scholar
• Brown D. W., Giles W. H., Croft J. B. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 2001; 54: 316–22
   PubMed Web of Science ®Google Scholar
• Lee C. D., Folsom A. R., Nieto F. J., Chambless L. E., Shahar E., Wolfe D. A. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African–American and White men and women: atherosclerosis risk in communities study. Am J Epidemiol 2001; 154: 758–64
   PubMed Web of Science ®Google Scholar
• Corre F., Lellouch J., Schwartz D. Smoking and leukocyte counts. Results of an epidemiological survey. Lancet 1971; 2: 632–4
   PubMed Web of Science ®Google Scholar
• Nieto F. J., Szklo M., Folsom A. R., Rock R., Mercuri M. Leukocyte count correlates in middle‐aged adults: the Atherosclerotic Risk in Communities (ARIC) Study. Am J Epidemiol 1992; 156: 525–37
   Google Scholar
• Friedman G. D., Tekawa I., Grimm R. H., Manolio T., Shannon S. G., Sidney S. The leucocyte count: correlates and relationship to coronary risk factors: the CARDIA study. Int J Epidemiol 1990; 19: 889–93
   PubMedGoogle Scholar
• Lowe G. D., Machado S. G., Krol W. F., Barton B. A., Forbes C. D. White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost 1985; 54: 700–3
   PubMedGoogle Scholar
• Hansen L. K., Grimm R. H., Jr, Neaton J. D. The relationship of white blood cell count to other cardiovascular risk factors. Int J Epidemiol 1990; 19: 881–8
   PubMed Web of Science ®Google Scholar
• Welch G. N., Loscalzo J. Homocysteine and atherosclerosis. N Engl J Med 1998; 338: 1042–50
   PubMed Web of Science ®Google Scholar
• Whitfield J. B. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38: 263–355
   PubMed Web of Science ®Google Scholar
• Shipchandler M. T., Moore E. G. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 1995; 41: 991–4
   PubMed Web of Science ®Google Scholar
• Hackam D. G., Peterson J. C., Spence J. D. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 µmol/l. Am J Hypertens 2000; 13: 105–10
   PubMed Web of Science ®Google Scholar
• Folsom A. R., Desvarieux M., Nieto F. J., Boland L. L., Ballantyne C. M., Chambless L. E. B vitamin status and inflammatory markers. Atherosclerosis 2003; 169: 169–74
   PubMedGoogle Scholar
• Saito I., Folsom A. R., Brancati F. L., Duncan B. B., Chambless L. E., McGovern P. G. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med 2000; 133: 81–91
   PubMedGoogle Scholar
• Dawson H., Collins G., Pyle R., Deep‐Dixit V., Taub D. D. The immunoregulatory effects of homocysteine and its intermediates on T‐lymphocyte function. Mech Ageing Dev 2004; 125: 107–10
   PubMed Web of Science ®Google Scholar
• Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003; 169: 203–14
   PubMed Web of Science ®Google Scholar
• Hoffman M., Blum A., Baruch R., Kaplan E., Benjamin M. Leukocytes and coronary heart disease. Atherosclerosis 2004; 172: 1–6
   PubMed Web of Science ®Google Scholar
• Wang G., Woo C. W., Sung F. L., Siow Y. L., O K. Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules. Arterioscler Thromb Vasc Biol 2002; 22: 1777–83
   PubMedGoogle Scholar
• Holven K. B., Aukrust P., Holm T., Ose L., Nenseter M. S. Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects. Arterioscler Thromb Vasc Biol 2002; 22: 699–703
   PubMed Web of Science ®Google Scholar
• Poddar R., Sivasubramanian N., DiBello P. M., Robinson K., Jacobson D. W. Homocysteine induces expression and secretion of moncyte chemoattractant protein‐1 and interleukin‐8 in human aortic endothelial cells: implications for vascular disease. Circulation 2001; 103: 2717–23
   PubMed Web of Science ®Google Scholar
• Koga T., Claycombe K., Meydani M. Homocysteine increases monocyte and T‐cell adhesion to human aortic endothelial cells. Atherosclerosis 2002; 161: 365–74
   PubMed Web of Science ®Google Scholar
• Zeng X., Dai J., Remick D. G., Wang X. Homocysteine mediated expression and secretion of monocyte chemoattractant protein‐1 and interleukin‐8 in human monocytes. Circ Res 2003; 93: 311–20
   PubMed Web of Science ®Google Scholar
• Dudman N. P., Temple S. E., Guo X. W., Fu W., Perry M. A. Homocysteine enhances neutrophil‐endothelial interactions in both cultured human cells and rats in vivo. Circ Res 1999; 84: 409–16
   PubMedGoogle Scholar
• Rothenbacher D., Fischer H. G., Hoffmeister A., Hoffmann M. M., Marz W., Bode G., et al. Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters. Atherosclerosis 2002; 162: 193–200
   PubMed Web of Science ®Google Scholar